KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Edwards Lifesciences (EW) Leases (2019 - 2025)

Edwards Lifesciences has reported Leases over the past 7 years, most recently at $102.7 million for Q4 2025.

  • Quarterly results put Leases at $102.7 million for Q4 2025, up 4.58% from a year ago — trailing twelve months through Dec 2025 was $102.7 million (up 4.58% YoY), and the annual figure for FY2025 was $102.7 million, up 4.58%.
  • Leases for Q4 2025 was $102.7 million at Edwards Lifesciences, up from $96.5 million in the prior quarter.
  • Over the last five years, Leases for EW hit a ceiling of $104.4 million in Q3 2024 and a floor of $84.2 million in Q2 2022.
  • Median Leases over the past 5 years was $91.5 million (2021), compared with a mean of $92.1 million.
  • Biggest five-year swings in Leases: grew 17.22% in 2021 and later decreased 8.56% in 2023.
  • Edwards Lifesciences' Leases stood at $92.1 million in 2021, then grew by 0.22% to $92.3 million in 2022, then decreased by 8.56% to $84.4 million in 2023, then rose by 16.35% to $98.2 million in 2024, then increased by 4.58% to $102.7 million in 2025.
  • The last three reported values for Leases were $102.7 million (Q4 2025), $96.5 million (Q3 2025), and $99.0 million (Q2 2025) per Business Quant data.